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Mesangial cell abnormalities in spontaneously hypertensive rats
before the onset of hypertension
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Mesangial cell abnormalities in spontaneously hypertensive rats before
the onset of hypertension. To identify kidney biosynthetic abnormalities
that may precede the onset of hypertension, we studied the expression of
fibronectin (FN) and collagen IV (Coil IV) in young SHR (4 weeks of age)
whose systolic blood pressure was normal and similar to that of age-
matched control WKY rats. In isolated glomeruli the level of FN protein
assessed by immunoblotting tended to be lower in the SHR than in the
WKY rats. By Northern analysis the FN/actin mRNA ratio was signifi-
cantly lower in glomeruli from SHR (0.56 0.47) than in glomeruli from
WKY rats (2.0 0.8). These abnormalities were maintained in vitro since
the expression of FN was significantly lower in SHR than in WKY cultured
mesangial cells (FN/actin mRNA ratio = 0.84 0.46 vs. 1.9 0.7, P =
0.029). No differences in Coil IV mRNA or protein levels were observed
in SHR glomeruli and mesangial cells when compared with WKY rats.
The levels of aortic FN and Coil IV mRNAs were not different in SHR
and WKY rats. In addition, mesangial cells from SHR showed a signifi-
cantly higher growth rate than those from WKY. The biosynthetic and
proliferative abnormalities observed in the SHR mesangial cells appear to
reflect genetic characteristics, and could provide novel insights into
cellular mechanisms linking the genetics of hypertension with predisposi-
tion to glomerular pathology.
Several lines of evidence suggest that the kidney plays a primary
role in the pathogenesis and maintenance of hypertension [1—7].
Patients with hypertensive nephrosclerosis had normalization of
their blood pressure after renal transplantation from donors
without a genetic background for hypertension [2]. Conversely,
genetically normotensive rats develop hypertension when receiv-
ing a kidney transplant from hypertensive strains of rats [4—6],
even when the donors are maintained normotensive throughout
life with an angiotensin-converting enzyme inhibitor [4]. Although
an impaired ability of the kidney to excrete sodium is likely to be
the final functional pathway to hypertension, both in human
essential hypertension and in hypertensive strains of rats [71, the
nature of the responsible cellular and genetic mechanisms remain
incompletely defined [7].
In patients with diabetes mellitus susceptibility to renal disease
is variable, and it has been suggested that an important contrib-
utor to such susceptibility is predisposition to hypertension
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[8—10]. However, the mechanisms by which the genetics of
hypertension magnify the risk of diabetic nephropathy in patients
with diabetes mellitus is not clearly understood. An increase in
mesangial cell volume or number and, especially, in mesangial
matrix are histological hallmarks of diabetic nephropathy, and the
degree of mesangial matrix expansion best predicts functional
abnormalities [11]. It may thus be asked whether the genetics of
hypertension specify an abnormal behavior of mesangial cells.
The identification of early abnormalities in the kidney of
individuals who are destined to become, but are not as yet,
hypertensive, could provide new insights relevant to the kidney
pathology and susceptibility to diabetic renal disease that accom-
pany the genetics of hypertension. Because such studies cannot
readily be performed in humans, we used a widely studied model
of essential hypertension, namely the spontaneously hyperten-
sive rat (SHR), which exhibits a normotensive period (the first 4
weeks of life) prior to the genetically determined development of
hypertension, which occurs in 100% of the animals [12]. The aim of
our study was to investigate if the kidney of young (4 weeks of age)
normotensive SHR displays biosynthetic and proliferative abnor-
malities when compared with the kidney of genetically normoten-
sive controls, the Wistar Kyoto (WKY) rats.
METHODS
Animals
SHR and WKY rats four weeks of age were obtained from
Taconic (Germantown, NY, USA). As noted by other investiga-
tors [13, 14], at this age SHR were smaller than WKY rats and had
a slightly higher blood pressure. In the 13 groups of rats used for
experiments the weight was 60 9 g for the SHR (N = 90) and
100 23 g for the WKY (N = 70; P < 0.001). Systolic blood
pressure was measured by Taconic on the day of shipment. Blood
pressure determinations were obtained by tail-cuff plethysmogra-
phy on unanesthetized rats (5 determinations in each rat) at 26°C
using a MK III physiograph (Narco Bio-System, Houston, TX,
USA). Systolic blood pressure was 124 12 mm Hg in the SHR
and 114 12 in the WKY (P < 0.05), documenting the absence
of hypertension. Experimental procedures were conducted ac-
cording to institutional and NIH guidelines and were approved by
the institutional Animal Care and Use Committee.
Isolation of kidney glomeruli and aortas
Rats were sacrificed by CO2 asphyxiation and the kidneys and
aortas were rapidly excised. Glomeruli were isolated by differen-
tial sieving technique [15, 161. Briefly, finely minced decapsulated
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kidney cortex was gently pressed and rinsed with Hank's balanced
salt solution (HBSS) through stainless steel screens (W. Tyler Co.,
Mentor, OH, USA) of 60 (pore size 250 jt)and 150 (pore size 106
) mesh, and the glomeruli were collected on 200 mesh screen
(pore size 53 j. The purity of the preparation, as assessed by
phase contrast microscopy, was approximately 95%. Glomeruli
were used to isolate RNA, study protein levels, and culture
mesangial cells. Aortas were removed taking care to avoid stretch-
ing or compressing the tissue. The region of the aorta extending
from the arch to the iliac bifurcation was used in all studies.
Aortas were carefully cleaned of periadventitial tissue, snap
frozen in liquid nitrogen, and stored at —80°C until processed for
RNA extraction.
Isolation and culture of mesangial cells
In each experiment the glomeruli isolated from 4 to 5 SHR and
3 to 4 WKY rats, respectively, were pooled and incubated in
HBSS containing 750 U/ml collagenase (CLS4; Worthington,
Freehold, NJ, USA) for 30 minutes at 37°C followed by a wash in
HBSS to remove epithelial cells [17]. The glomerular remnants
were plated in 60 mm tissue culture dishes (Falcon Primaria;
Becton Dickinson, Lincoln Park, NJ, USA), and cultured in
RPMI-1640 tissue culture medium (Gibco, Grand Island, NY),
buffered with 15 mrvi Hepes (Sigma Chemical Co., St Louis, MO)
and containing 20% decomplemented fetal bovine serum (Sig-
ma), 10 m glucose, penicillin (60 U/ml), streptomycin sulfate
(60 j.g/ml), and fungizone (50 g/ml) (Gibco). Incubation was
at 37°C in 5% CO2 and 95% air; the media were changed every
48 to 72 hours. Mesangial cells outgrowths appeared after 2 to
3 days in culture and reached confluence after 10 days. The
cells were passaged every 7 to 10 days using trypsin-EDTA
(Gibco). Confluent dishes of cells from passage three to four,
when contamination by other cell types such as endothelial or
epithelial was virtually absent, were used for all experiments.
Mesangial cells in culture were identified by phase-contrast
microscopy on the basis of their characteristic stellate to
fusiform morphology [18]; in addition the cells were negative
for both uptake of acetylated-low density lipoprotein (Biomed-
ical Technologies Inc., Stoughton, MA, USA) and staining with
keratin antibodies (ICN Biomedicals, Costa Mesa, CA, USA),
thus excluding contamination with endothelial and epithelial
cells, respectively.
Northern blot analysis
Total RNA was extracted from the isolated glomeruli, aortic
tissue, and cultured mesangial cells at confluence using the
guanidine thiocyanate method [191, and the RNA samples (15 ig)
were size-fractionated by elcctrophoresis on 1% agarose gel
containing 2.2 M formaldehyde. Lack of degradation was verified
by acridine orange staining of the 28S and 18S rRNA bands.
Northern blot onto nylon membranes (Nytran; Schleicher &
Schuell, Inc., Keene, NH, USA) was performed as described
previously [20]. Blots were hybridized [20] for 12 to 48 hours at
42°C to a 32P-labeled rat fibronectin cDNA consisting of a 582 bp
fragment obtained by polymerasc chain reaction [21], a mouse
collagen a (IV) eDNA (gift of Dr. M. Kurkinen) [22], and
chicken f3-actin cDNA (Oncor, Gaithersburg, MD, USA). After
hybridization, the nylon membranes were washed twice in 6 X
SSPE [20], 0.1% SDS at 37°C, and two more times in I X SSPE,
0.1% SDS at 55°C. The membranes were exposed to Kodak
X-Omat film at —80°C for 4 to 6 hours (actin), 12 to 96 hours
(fibronectin) and 24 to 48 hours (collagen IV). Laser densitome-
try, performed using the Model 330A computing densitometer
(Molecular Dynamics, Sunnyvale, CA, USA) was used to quanti-
tate signal intensity. Results are expressed as fibronectin/actin and
collagen IVlactin ratios.
Western blot analysis
Freshly isolated glomeruli were homogenized in a buffer con-
taining 30 mM Tris-HC1, pH 7.5, 10 mM EGTA, 5 mM EDTA, 1
mM dithiothreitol, and 250 m sucrose at a 10:1 ratio (vol/vol) of
buffer to tissue wet wt. The homogenate was sonicated three times
for five seconds. An aliquot of 10 1td was separated for protein
quantitation performed by the Bradford procedure [23] with
bovine serum albumin as the standard. The remaining homoge-
nate was mixed in Laemmli sample buffer [24], heated at 100°C for
five minutes, and stored at —80°C.
Five, ten and fifteen micrograms of total protein from glomeruli
of SHR and WKY rats, respectively, were analyzed by SDS-
polyacrylamide gel electrophoresis as described by Laemmli [24]
on linear 4 to 20% acrylamide gradient separating gels, using
Mini-Protean II Dual Slab Cell apparatus (Bio-Rad Laboratories,
Hercules, CA, USA). Transfer onto nitrocellulose membranes
was done at room temperature for two hours at constant current
(200 mA). The membranes were blocked overnight at 4°C in 5%
dried milk in buffer containing 10 m'vi Tris-HC1 pH 8.0, 150 mM
NaC!, and 0.05% Tween-20 (TBST), and then incubated with the
primary antibody for one hour at room temperature. A mouse
anti-rat fibronectin monoclonal antibody (BR 5.3; gift of Dr. R.
Hynes) [251 was used diluted 1:100 in TBST, and a rabbit
antiserum against rat type IV collagen (gift of Dr. R.G. Spiro) [261
was used diluted 1:200 in TBST. The membranes were washed
three times in TBST and incubated with the appropriate second-
ary antibody conjugated to horseradish peroxidase. The anti-
mouse secondary antibody was diluted 1:2000 in TBST, and the
anti-rabbit 1:5000. Immunoreactive bands were visualized using
the enhanced chemiluminescence method (SuperSignal° CL-
HPR Substrate System; Pierce, Rockford, IL, USA) according to
manufacturer's protocol.
Densitometric analysis of the autoradiographs was done
through the Model 300 A computing densitometer. The values for
signals generated by the increasing amounts of sample lysate (5,
10, and 15 ig of total protein) were averaged to yield the
fibronectin and collagen IV values for each sample (densitometric
U/jig total protein). For quantitation of type IV collagen, the
absorbance of the al-chain (°° 200,000 Mr) was measured.
Fibronectin was determined on the basis of its 230,000-Mr
component.
Cell proliferation
To estimate the rate of growth of mesangial cells of SHR and
WKY rats, cells companion to those destined to mRNA and
protein experiments, were plated onto 24-well plates at 10,000
cells/well. The cell numbers were determined [27] in triplicate on
days 2, 7 and 12 after plating.
Statistical analysis
Data are presented as mean SD. The weight and blood
pressure values of SHR and WKY rats, as well as the results
Fig. 1. Fibronectin protein and mRNA levels in
isolated glomeruli of WKY and SHR. (A)
Immunological detection (Western blot) of
glomerular fibronectin. Two experiments are
depicted; in each experiment glomeruli were
pooled from 3 WKY rats and 4 SHR,
respectively, and the glomerular lysates were
subjected to PAGE (5, 10, and 15 pg of total
protein per lane) and immunoblotted with anti-
rat fibronectin antibodies as described in
Methods. Designated molecular weight markers
are myosin (220 K) and phosphorylase b (97.4
K). K is kiloDaltons. (B, left) Northern blot of
glomerular fibronectin and p-actin. Each lane
contains 15 pg of total RNA extracted from
glomeruli pooled from 3 WKY and 4 SHR.
Blots were hybridized with rat fibronectin
cDNA and a chicken f3-actin cDNA as
described in the Methods section. kb is
kilobases. (B, right) Fibronectin/actin mRNA
ratio as determined by Northern blot analysis in
isolated glomeruli of WKY rats (Lii) and SHR
(U). Each bar represents the mean SD of the
results obtained in three experiments.
In freshly isolated glomeruli the level of immunoreactive fi-
bronectin as detected by Western blots (Fig. 1A) tended to be
lower in the SHR than in the WKY rats (mean SD, 29 8 and
48 30 densitometric U/itg total protein, P = 0.2, N = 4).
Although differences could not be accounted for by differences in
plasma fibronectin because Western blot analysis showed similar
levels of plasma fibronectin in SI1R (2464 318 densitometric
units/lO d of plasma) and WKY (2230 331), we could not
exclude confounding influences by plasma trapped in the tissue.
We thus examined the level of fibronectin mRNA. The fibronec-
tin/actin mRNA ratio was significantly lower (P = 0.05) in
glomeruli from SHR (0.56 0.47) than in glomeruli from WKY
rats (2.0 0.8; Fig. 1B). Actin could appropriately be used as
control for RNA loading because the levels of actin mRNA were
similar in the glomeruli of SHR (2352 2965 densitometric units)
and WKY rats (1941 1719).
At variance with fibronectin, the levels of collagen IV were
similar in the SHR and WKY glomeruli. In four experiments,
collagen IV protein was 136 62 densitometric U/pg total
protein in the SHR and 142 47 in the WKY rats; in two
experiments the collagen IV/actin mRNA ratio was 1.23 0.3 in
SHR and 1.74 0.7 in WKY rats.
To examine whether the lower level of fibronectin expression
observed in the SHR glomeruli reflected an intrinsic biosynthetic
characteristic of mesangial cells, these cells were cultured from
glomeruli of SHR and WKY rats, and tested at the third or fourth
passage. The fibronectin/actin mRNA ratio was significantly
lower (P = 0.03) in mesangial cells of SHR (0.84 0.46) than
in mesangial cells of WKY rats (1.9 0.7; Fig. 2). The IV/actin mRNA ratio was similar in the mesangial cells of SHR
magnitude of the difference (2.2-fold less fibronectin mRNA in (2.4 1.0) and WKY rats (2.4 1.2), as was the level of actin
SHR mesangial cells) was similar to that observed in freshly mRNA (2203 906 densitometric units in SHR and 2542
isolated glomeruli (3.5-fold). In four experiments, the collagen 1550 in WKY rats).
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obtained in the Northern and Western blots and in the cell
proliferation studies were compared using the two-tailed unpaired
Student's t-test.
RESULTS
3
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Fig. 2. Fibronectin and 13-actin mRNA levels in cultured mesangial cells
of WKY and SHR. (Top) Northern blots (15 pg total RNMane). Each lane
represents a different mesangial cell isolate, cultured from a pool of glomeruli
isolated from WKY rats and SHR, respectively. Two experiments are
depicted. (Bottom) Fibronectin/actin mRNA ratios as determined by North-
ern analysis in mesangial cells of WKY rats (liii) and SHR (U). Each bar
represents the mean SD of the results obtained in three experiments.
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To ascertain if other tissues in the SHR exhibited fibronectin
mRNA levels lower than in the WKY rats, the aortas of the same
animals from which kidneys were obtained, were also studied. The
fibronectin/actin mRNA ratio of aortic tissue was found in four
experiments to be similar in the SHR (0.47 0.30) and WKY rats
(0.64 0.41, P = 0.5; Fig. 3), as were collagen IV/actin mRNA
ratio (0.24 0.23 in the SI-IR and 0.27 0.12 in the WKY rats)
and -actin mRNA levels (3648 1460 densitometric units in the
SHR and 4335 2393 in the WKY).
We observed that the mesangial cells obtained from the SI-IR
proliferated in culture at a faster rate than the cells obtained
from the WKY rats. The impression was confirmed by the
results of formal proliferation experiments (Fig. 4). At day 2
the number of SHR mesangial cells was similar to that of
mesangial cells from the WKY rats excluding differences in
plating efficiency, but it was 4.4-fold greater at days 7 and 12
(P = 0.001).
DISCUSSION
We observed that, when compared with the genetically normo-
tensive WKY rats, SHR four weeks of age and still normotensive
exhibit lower expression of fibronectin in the kidney glomeruli and
cultured mesangial cells, and an accelerated proliferation of
mesangial cells in vitro. Insofar as the glomerular collagen IV and
-actin expression did not differ between the SHR and WKY rats,
the biosynthetic abnormality appears to be product-specific; and
because aortic fibronectin mRNA levels were similar in the SHR
and WKY rats, it appears to be organ-specific. The fact that the
reduced basal expression of glomerular fibronectin occurring in
vivo in the SHR was maintained in their cultured mesangial cells
indicates that the abnormality detected in vivo is contributed, at
least in part, by the mesangial cell component of the glomeruli,
and that it does not reflect levels of microenvironmental regula-
tion possibly lost in vitro, but rather genetic characteristics intrin-
sic to the mesangial cells.
These observations may have relevance to the mechanisms
underlying the severe glomerular sclerosis that develops progres-
sively in SHR, even when the rats are maintained normotensive
with drug treatment [281. Gene targeting experiments have re-
cently demonstrated a critical role for flbronectin in vascular
development [29], and an abnormally low expression of fibronec-
tin in the SHR glomcruli might, if present during embryogenesis,
compromise in some subtle way the development of the glomeruli
and render them prone to pathology later in life. Additionally, a
contribution may be made by accelerated mesangial cell prolifer-
ation. The level of fibronectin synthesis and cellular proliferation
are, in some systems, inversely related. For example, overexpres-
sion of fibronectin during in vivo and in vitro aging of vascular
endothelial cells and fibroblasts is coincidental with a decreased
labeling index [30], and similar observations have been made in
endothelial cells exposed to exogenous perturbations that
increase fibronectin synthesis [31]. The reduced fibronectin
synthesis and greater proliferative potential of SHR mesangial
cells may thus represent two facets of the same cellular
abnormality, and because dysregulation of mesangial cell mi-
togenesis is viewed as an early prerequisite for the development
of glomerulosclerosis [321, such abnormality may have rele-
vance to the kidney pathology of SHR.
The finding of greater proliferative potential of the mesangial
cells in a genetic model of hypertension may also be relevant to
the mechanisms underlying the predisposition to diabetic ne-
phropathy of individuals with a family history of hypertension
[8—10]. In fact, it has been recently reported that fibroblasts
explanted from such individuals and cultured in vitro for several
generations manifest accelerated growth when compared with
fibroblasts from diabetic patients without nephropathy and non-
diabetic control subjects [33—35]. It could be envisioned that, if the
abnormal growth phenotype is also manifested in the mesangial
cells of individuals prone to hypertension as it is in the pre-
hypertensive SHR, and translates into accelerated turnover in
vivo, it may play a critical role in the mesangial expansion that
eventually leads to clinical nephropathy. The contribution would
be not only through cellular hyperplasia, but also through a
deposition of extracellular matrix made overabundant by the
greater number of contributing cell generations, especially under
the stimulatory effect of the high glucose levels [36]. Of interest,
SHR made diabetic with streptozotocin manifest features of
accelerated nephropathy when compared with diabetic WKY rats
or control SHR, but fractional mesangial volume not greater than
Fig. 3. Fibronectin and -actin mRNAs in aortas of WKY and SHR.
RNA was extracted from a pool of 3 to 4 aortas of WKY and SHR,
respectively, and sobjeeted to Northern blot analysis @5 .tg of total
RNA/lane).
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Fig. 4. Proliferation of cultured mesangial cells of WKY and SHR.
Mesangial cells from WKY (0) and SHR (•) were concomitantly plated,
in triplicate, at 10,000 cells/well of a 24-well plate. The cells were harvested
and counted on days 2, 7 and 12 after plating. Each point represents the
mean so of the results obtained in 4 independent experiments.
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the other two groups [37]. However, mesangial volume was
measured at 32 weeks, after a prolonged course of both diabetes
and hypertension, and the influence of hemodynamic abnormali-
ties and possible incipient glomerular sclerosis occurring in the
SHR [28] represent confounding features. Hamaguchi et a! [38]
reported that the glomeruli and other kidney structures of hyper-
tensive SHR exhibit a greater number of replicating cells than the
kidneys of WKY rats, and that the number is reduced by
antihypertensive treatment. However, the investigators failed to
indicate if treatment fully corrected the increased replication
observed in the SHR.
It appears that to establish whether there is an in vivo counter-
part to the abnormal growth phenotype of SHR mesangial cells
that is solely attributable to the genetics of hypertension will
require studies in the pre-hypertensive SHR. Such studies are
made especially desirable by the findings in fibroblasts explanted
from diabetic patients with nephropathy [33—35], which indirectly
propose that genetically determined abnormalities in growth
regulation may be a mechanism for the tendency to develop
glomerular pathology.
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